3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
11
Active not recruiting
6
Terminated
5
Recruiting
2
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Central Nervous System Neoplasms
2
Waldenstrom Macroglobulinemia
1
Sezary Syndrome
1
Sarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Mycosis Fungoides
1
Medulloblastoma
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Interventions
Cyclophosphamide
5
nilotinib
4
Cytarabine
4
fludarabine
3
Methotrexate
3
Imatinib Mesylate
3
Dasatinib
3
Busulfan
3
fludarabine phosphate
2
Peripheral Blood Stem Cell Transplantation
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Cyclosporine
2
AP 1903 reagent
2
sargramostim
1
ruxolitinib
1
merphos
1
amsonic acid
1
Whole-Body Irradiation
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Tacrolimus
1
Sirolimus
1
Saline Solution
1
Rituximab
1
Prednisone
1
Ondansetron
1
Mesna
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Thiotepa
×
Clear all
NCT04282174
2022-09-27
2019-KOE-001
Baptist Health South Florida
Phase 2
Withdrawn